BRADLEY T. SHEARES, PH.D. - Corporate Board Profile

HENRY SCHEIN INC

Filing Date	Source Excerpt
2015-04-24	Bradley T. Sheares, Ph.D. has been a director since 2010. The Strategic Advisory Committee currently consists of Messrs. Matthews (Chairman), Brons and Laskawy and Drs. Sheares and Sullivan. Director Compensation Table shows $255,900 total compensation for Dr. Sheares in 2014.
2016-04-11	Bradley T. Sheares, Ph.D. has been a director since 2010. ... Director Compensation for Fiscal 2015 ... Bradley T. Sheares, Ph.D. ... Fees Earned or Paid in Cash $67,000 ... Stock Awards $185,400 ... Total $252,400
2017-04-10	Bradley T. Sheares, Ph.D. has been a director since 2010. The Compensation Committee currently consists of Messrs. Alperin (Chairperson) and Kabat and Dr. Sheares. The Nominating and Governance Committee currently consists of Messrs. Laskawy (Chairperson) and Alperin and Drs. Bacow and Sheares. The Strategic Advisory Committee currently consists of Dr. Rekow (Chairperson), Messrs. Brons, Herring and Laskawy, Ms. Raphael and Drs. Bacow and Sheares. Director Compensation for Fiscal 2016 shows total compensation of $268,400 for Dr. Sheares.
2018-04-12	Bradley T. Sheares, Ph.D. has been a director since 2010. The Compensation Committee currently consists of Messrs. Alperin (Chairperson) and Kabat and Drs. Bacow and Sheares. The Strategic Advisory Committee currently consists of Dr. Rekow (Chairperson), Messrs. Brons, Herring and Laskawy, Ms. Raphael and Drs. Bacow and Sheares. Director compensation table shows $279,400 total.
2019-04-09	Bradley T. Sheares, Ph.D. has been a director since 2010. Dr. Sheares served as Chief Executive Officer of Reliant Pharmaceuticals, Inc., from January 2007 through its acquisition by GlaxoSmithKline plc in December 2007. Prior to joining Reliant, from 2001 until 2006, Dr. Sheares served as President of U.S. Human Health for Merck & Co. As a member of Merck’s management committee, Dr. Sheares had responsibility for formulating global business strategies, operations management and the development and implementation of corporate policies. As the former Chief Executive Officer of Reliant Pharmaceuticals and with 20 years in the pharmaceutical industry, Dr. Sheares brings to the Company’s Board of Directors extensive health care knowledge and experience in sales, marketing, brand management, research and development, complex regulatory and legal issues, risk management and mergers and acquisitions. As a director of other public companies, Dr. Sheares has been involved in succession planning, compensation, employee management and the evaluation of acquisition opportunities. Director Compensation for Fiscal 2018: Total $282,177.
2020-04-07	Bradley T. Sheares, Ph.D. has been a director since 2010. Dr. Sheares served as Chief Executive Officer of Reliant Pharmaceuticals, Inc., from January 2007 through its acquisition by GlaxoSmithKline plc in December 2007. Prior to joining Reliant, from 2001 until 2006, Dr. Sheares served as President of U.S. Human Health for Merck & Co. As a member of Merck’s management committee, Dr. Sheares had responsibility for formulating global business strategies, operations management and the development and implementation of corporate policies. As the former Chief Executive Officer of Reliant Pharmaceuticals and with 20 years in the pharmaceutical industry, Dr. Sheares brings to the Company’s Board of Directors extensive health care knowledge and experience in sales, marketing, brand management, research and development, complex regulatory and legal issues, risk management and mergers and acquisitions. As a director of other public companies, Dr. Sheares has been involved in succession planning, compensation, employee management and the evaluation of acquisition opportunities. During the past five years, Dr. Sheares served as a director of Covance Inc., Honeywell International, Inc. and The Progressive Corporation. Director Compensation for Fiscal 2019: Total $310,800.
2021-03-30	Bradley T. Sheares, Ph.D. has been a director since 2010. Dr. Sheares served as Chief Executive Officer of Reliant Pharmaceuticals, Inc.
2022-04-06	Bradley T. Sheares, Ph.D. has been a director since 2010. ... Compensation Committee currently consists of Dr. Sheares (Chairperson) ... Nominating and Governance Committee currently consists of Dr. Sheares ... Strategic Advisory Committee currently consists of Dr. Sheares (Chairperson) ... Director Compensation for Fiscal 2021: Bradley T. Sheares total $321,800.
2023-04-11	Bradley T. Sheares, Ph.D. has been a director since 2010. ... The Compensation Committee currently consists of Ms. Derby (Chairperson), Mr. Herring and Dr. Sheares. ... The Nominating and Governance Committee currently consists of Mr. Laskawy (Chairperson), Ms. Derby and Dr. Sheares. ... The Strategic Advisory Committee currently consists of Drs. Sheares (Chairperson) and Tuckson, Messrs. Ali, Herring and Serota and Ms. Raphael. ... Director Compensation for Fiscal 2022: Bradley T. Sheares total compensation $313,000.
2024-04-10	Bradley T. Sheares, Ph.D. has been a director since 2010. ... The Compensation Committee currently consists of Ms. Derby (Chairperson), Mr. Herring and Dr. Sheares. ... Director Compensation for Fiscal 2023: Bradley T. Sheares Fees Earned or Paid in Cash $129,200, Stock Awards $175,000, Total $304,200.